ASSAN

Human CLDN18.2/PA-TU 8902 Stable Cell Line


Catalog Number Product Size Price
C3001 Human CLDN18.2/PA-TU 8902 Stable Cell Line 2 vials $8000 Order

Product Specifications


Catalog Number C3001
Cell Line Name Human CLDN18.2/PA-TU 8902 Stable Cell line
Accession Number NP_001002026.1
Host Cell PA-TU 8902, a human pancreatic adenocarcinoma cell line
Quantity Two vials of frozen cells (1x106 per vial)
Culture Medium DMEM with 10% FBS, 1 ug/ml puromycin
Freezing Medium 90% FBS and 10% DMSO
Storage Liquid nitrogen upon receipt
Product Datasheet: Download PDF

Representative Data


Detection of human CLDN18.2 expression on human CLDN18.2/PA-TU 8902 stable cells using a monoclonal antibody specific for human CLDN18.2 at two different concentrations(5 and 0.5ug/ml)


Background


Claudin-18 (CLDN18) is a member of a large family of four-span transmembrane proteins called Claudins. These proteins are the essential components of the mammalian tight junctions (TJs) in epithelial cells. Claudin-18 has two splice variants, 18.1 and 18.2. While CLDN18.1 is specifically expressed in the lung tissue, CLDN18.2 expression in normal tissue is more restricted and is only detected in small patches of stomach mucosal. CLDN18.2 expression is elevated in many types of epithelial cancers including stomach, esophagus, pancreatic and ovarian cancers. The expression of CLDN18.2 is not only detected in primary tumors, but also in the metastatic sites. Therefore, CLDN18.2 is an ideal target for monoclonal antibody-based cancer therapies.

References

Elsasser HP. et al. Structural analysis of a new highly metastatic cell line Pa-Tu 8902 from a primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 64(4):201-7. 1993.

Tureci O. et al. Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals. Gene. 481(2): 83-92. 2011.

Sahin U. et al. Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development. Clin. Cancer Res. 14(23):7624-7634. 2008.